Back to Top
Insulin Biosimilar - Research Grade
$710.00 - $6,900.00
Insulin Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
INSRï؟½
Concentration
5mg/ml
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
P06213
Shipping Conditions
Blue ice
Background
Signaling through the insulin receptor (INSR) coordinates glucose uptake and metabolic homeostasis, anchoring a vast body of endocrine and diabetes research. This research-grade reagent is an unconjugated, non-therapeutic analog of insulin engaging the human receptor and is offered exclusively for research use only (RUO). It is supplied in a low-endotoxin format compatible with in vivo metabolic studies and is produced across milligram to gram scales to serve heavy-usage and high-throughput workflows. Investigators use it in receptor-binding and signaling assays, in vitro screening, and preclinical metabolic disease models, where it acts as a reliable, non-therapeutic reference reagent during functional and comparative experiments.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review













